Pharma & Biotech
Crypto
Gold & Silver
Battery Metals
Artificial Intelligence
You will receive alerts when there are new announcements on ADC Therapeutics SA
Only registered members can use this feature.
or
ADC Therapeutics develops and commercialises antibody-drug conjugates for cancer. Its marketed product Zynlonta is used to treat certain patients with diffuse large B-cell lymphoma.
© Proactive Group Holdings, Inc. All Rights Reserved.
Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use.